Evidence map›Paper›PMID 37435522›Full record

ArticleFrontiers in public health2023

HIV and HCV screening by non-infectious diseases physicians: can we improve testing and hidden infection rates?

Alejandro G García-Ruiz de Morales, Javier Martínez-Sanz, María J Vivancos-Gallego, Matilde Sánchez-Conde, Manuel Vélez-Díaz-Pallarés, Beatriz Romero-Hernández, María Dolores González Vázquez, Carmen María Cano de Luque, Ander González-Sarria, Juan Carlos Galán and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 2 countries.

Alejandro G García-Ruiz de MoralesDepartment of Infectious Diseases, Hospital Universitario Ramón y Cajal and Instituto de Investigación Sanitaria Ramón y Cajal (IRYCIS), Madrid, Spain.
Javier Martínez-SanzDepartment of Infectious Diseases, Hospital Universitario Ramón y Cajal and Instituto de Investigación Sanitaria Ramón y Cajal (IRYCIS), Madrid, Spain.
María J Vivancos-GallegoDepartment of Infectious Diseases, Hospital Universitario Ramón y Cajal and Instituto de Investigación Sanitaria Ramón y Cajal (IRYCIS), Madrid, Spain.
Matilde Sánchez-CondeDepartment of Infectious Diseases, Hospital Universitario Ramón y Cajal and Instituto de Investigación Sanitaria Ramón y Cajal (IRYCIS), Madrid, Spain.
Manuel Vélez-Díaz-PallarésDepartment of Pharmacy, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria IRYCIS, Madrid, Spain.
Beatriz Romero-HernándezDepartment of Microbiology, Hospital Universitario Ramón y Cajal and IRYCIS, Madrid, Spain.
María Dolores González VázquezDepartment of Internal Medicine, Hospital de Braga, Braga, Portugal.
Carmen María Cano de LuqueDepartment of Internal Medicine, Hospital Clínico San Carlos, Madrid, Spain.
Ander González-SarriaDepartment of Microbiology, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain.
Juan Carlos GalánDepartment of Microbiology, Hospital Universitario Ramón y Cajal and IRYCIS, Madrid, Spain.
Francisco Gea RodríguezDepartment of Gastroenterology, Hospital Universitario Ramón y Cajal and IRYCIS, Madrid, Spain.
Santiago MorenoDepartment of Infectious Diseases, Hospital Universitario Ramón y Cajal and Instituto de Investigación Sanitaria Ramón y Cajal (IRYCIS), Madrid, Spain.
María Jesús Pérez-ElíasDepartment of Infectious Diseases, Hospital Universitario Ramón y Cajal and Instituto de Investigación Sanitaria Ramón y Cajal (IRYCIS), Madrid, Spain.
Hospital Universitario Ramón y Cajal · ESCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESInstituto de Salud Carlos III · ESInstituto Ramón y Cajal de Investigación Sanitaria · ESCentro de Investigación Biomédica en Red · ESHospital Braga · PTHospital Clínico San Carlos · ESHospital Universitario Príncipe de Asturias · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Missed opportunities for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) testing remain high. We aimed to ascertain the knowledge of screening guidelines and attitudes of non-infectious disease (ID) hospital physicians and assess the impact of a 1-h session on screening rates and diagnoses. Methods: This interventional study consisted of a 1-h training session on HIV and HCV epidemiology and testing guidelines for non-ID physicians. Pre-and post-session questionnaires compared the knowledge of the guidelines and attitudes toward screening before and after the session. Rates of screening and diagnoses were compared in three 6 months periods: before, immediately after, and 24 months ±4 after the session. Results: A total of 345 physicians from 31 departments participated in these sessions. Before the session, 19.9% (28% medical, 8% surgical) and 17.9% (30% medical, 2.7% surgical) were aware of HIV and HCV testing guidelines, respectively. The willingness to routinely test increased from 5.6 to 22%, whereas not ordering tests decreased from 34.1 to 2.4%. HIV screening rates significantly increased by 20% after the session (7.7 vs. 9.3 tests per 103 patients; Conclusion: A short session for non-ID physicians can improve HIV/HCV screening, increase diagnosis, and contribute to disease elimination.

Indexed as

Hepatitis CHIV InfectionsNoncommunicable DiseasesPhysiciansHepacivirusHumansdiagnostic screening programsformative sessionHCV testingHIV testinghospital interventionlate diagnosismissed opportunitiesscreening

Identifiers

PMID37435522
PMCPMC10332317
OpenAlexW4382055489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.